1
Clinical Trials associated with HQ2216评价HQ2216注射液在中国健康受试者中的安全性、耐受性及药代动力学/药效学(PK/PD)特征的Ⅰa期临床研究
[Translation] A Phase Ia clinical study to evaluate the safety, tolerability and pharmacokinetic/pharmacodynamic (PK/PD) characteristics of HQ2216 injection in Chinese healthy subjects
考察在中国健康成年受试者单次注射HQ2216注射液的安全性、耐受性和药代动力学特征,比较其与对照药品的生物利用度及药代动力学/药效学特征,为后期研究的剂量选择提供理论依据。
[Translation] To investigate the safety, tolerability and pharmacokinetic characteristics of a single injection of HQ2216 injection in healthy adult subjects in China, and to compare its bioavailability and pharmacokinetic/pharmacodynamic characteristics with those of control drugs, so as to provide a theoretical basis for dose selection in subsequent studies.
100 Clinical Results associated with HQ2216
100 Translational Medicine associated with HQ2216
100 Patents (Medical) associated with HQ2216
100 Deals associated with HQ2216